Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Consolidated Net Profit

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹381 Cr₹314 Cr₹266 Cr₹185 Cr₹236 Cr

What is the latest Consolidated Net Profit of MARKSANS PHARMA ?

The latest Consolidated Net Profit ratio of MARKSANS PHARMA is ₹381 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹381 Cr
Mar2024₹314 Cr
Mar2023₹266 Cr
Mar2022₹185 Cr
Mar2021₹236 Cr

How is Consolidated Net Profit of MARKSANS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹381 Cr
21.32
Mar2024 ₹314 Cr
17.80
Mar2023 ₹266 Cr
44.29
Mar2022 ₹185 Cr
-21.77
Mar2021 ₹236 Cr -

Compare Consolidated Net Profit of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,212.2 Cr 0.2% 19.1% -0.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,036.0 Cr 0.8% -4.2% 7% Stock Analytics
DIVIS LABORATORIES ₹178,218.0 Cr 1.1% -0.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,099.0 Cr 0% 1.3% 40.1% Stock Analytics
CIPLA ₹110,897.0 Cr -0.3% -4.1% -8.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,591.0 Cr 0.4% -4.5% -5.2% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

0.2%

19.1%

-0.2%

SENSEX

3.9%

1.9%

-6.8%


You may also like the below Video Courses